SARS-CoV-2-ORF-3a Mediates Apoptosis Through Mitochondrial Dysfunction Modulated by the K+ Ion Channel.
Muhammad Suhaib Qudus1, Uzair Afaq1, Siyu Liu1
1State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, China.
International Journal of Molecular Sciences
|February 26, 2025
Summary
Severe COVID-19 lung damage is caused by the SARS-CoV-2 ORF-3a protein disrupting mitochondrial function. Restoring potassium levels can mitigate this damage and inflammation, suggesting new therapeutic targets.
Area of Science:
- Virology
- Cellular Biology
- Pathology
Background:
- COVID-19, caused by SARS-CoV-2, leads to severe lung damage and cell death.
- The precise molecular mechanisms driving SARS-CoV-2-induced apoptosis remain unclear.
- Pulmonary edema and alveolar-capillary barrier disruption are key pathological features.
Purpose of the Study:
- To elucidate the molecular mechanisms of SARS-CoV-2-induced pulmonary cell apoptosis.
- To identify the role of SARS-CoV-2 ORF-3a protein in COVID-19 pathology.
- To investigate potential therapeutic targets for mitigating SARS-CoV-2 lung injury.
Main Methods:
- In vitro studies using SARS-CoV-2 ORF-3a.
- Analysis of mitochondrial homeostasis and apoptosis pathways.
- Assessment of the impact of exogenous potassium (K+) on cellular responses.
Main Results:
- SARS-CoV-2 ORF-3a was identified as a mediator of lung tissue damage.
- ORF-3a disrupts mitochondrial homeostasis by regulating the Mitochondrial ATP-sensitive Potassium Channel (MitoKATP).
- Exogenous potassium (K+) addition attenuated ORF-3a-induced mitochondrial apoptosis and interferon-beta (IFN-β) response.
Conclusions:
- Dysregulation of potassium ion channel function is central to SARS-CoV-2 ORF-3a-induced mitochondrial dysfunction.
- Targeting potassium channels or their interaction with ORF-3a presents a promising therapeutic strategy.
- This research offers insights into mitigating the severe lung pathology associated with SARS-CoV-2 infection.
Related Concept Videos
The Intrinsic Apoptotic Pathway
6.0K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.0K
The Extrinsic Apoptotic Pathway
5.9K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.9K
Apoptosis
10.6K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
10.6K
Caspases
11.9K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
11.9K
Autophagic Cell Death
3.0K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.0K
Overview of Cell Death
6.3K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
6.3K


